| Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies L Wu, LL van den Hoogen, H Slater, PGT Walker, AC Ghani, CJ Drakeley, ... Nature 528 (7580), S86-S93, 2015 | 249 | 2015 |
| Oral, ultra–long-lasting drug delivery: application toward malaria elimination goals AM Bellinger, M Jafari, TM Grant, S Zhang, HC Slater, EA Wenger, S Mo, ... Science translational medicine 8 (365), 365ra157-365ra157, 2016 | 228 | 2016 |
| The Relative Contribution of Symptomatic and Asymptomatic Plasmodium vivax and Plasmodium falciparum Infections to the Infectious Reservoir in a Low … FG Tadesse, HC Slater, W Chali, K Teelen, K Lanke, M Belachew, ... Clinical infectious diseases 66 (12), 1883-1891, 2018 | 191 | 2018 |
| The potential public health consequences of COVID-19 on malaria in Africa E Sherrard-Smith, AB Hogan, A Hamlet, OJ Watson, C Whittaker, ... Nature medicine 26 (9), 1411-1416, 2020 | 188 | 2020 |
| Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey JB Parr, R Verity, SM Doctor, M Janko, K Carey-Ewend, BJ Turman, ... The Journal of infectious diseases 216 (1), 36-44, 2017 | 179 | 2017 |
| The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density HC Slater, A Ross, I Felger, NE Hofmann, L Robinson, J Cook, ... Nature communications 10 (1), 1433, 2019 | 170 | 2019 |
| Predicting the current and future potential distributions of lymphatic filariasis in Africa using maximum entropy ecological niche modelling H Slater, E Michael PloS one 7 (2), e32202, 2012 | 166 | 2012 |
| Assessing the impact of next-generation rapid diagnostic tests on Plasmodium falciparum malaria elimination strategies HC Slater, A Ross, AL Ouédraogo, LJ White, C Nguon, PGT Walker, ... Nature 528 (7580), S94-S101, 2015 | 164 | 2015 |
| Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a … MR Smit, EO Ochomo, G Aljayyoussi, TK Kwambai, BO Abong'o, T Chen, ... The Lancet Infectious Diseases 18 (6), 615-626, 2018 | 134 | 2018 |
| Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study OJ Brady, HC Slater, P Pemberton-Ross, E Wenger, RJ Maude, AC Ghani, ... The Lancet Global Health 5 (7), e680-e687, 2017 | 133 | 2017 |
| Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial AL Ouédraogo, GJH Bastiaens, AB Tiono, WM Guelbéogo, KC Kobylinski, ... Clinical Infectious Diseases 60 (3), 357-365, 2015 | 128 | 2015 |
| Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial BD Foy, H Alout, JA Seaman, S Rao, T Magalhaes, M Wade, S Parikh, ... The Lancet 393 (10180), 1517-1526, 2019 | 123 | 2019 |
| The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study HC Slater, PGT Walker, T Bousema, LC Okell, AC Ghani The Journal of infectious diseases 210 (12), 1972-1980, 2014 | 118 | 2014 |
| Modelling the drivers of the spread of Plasmodium falciparum hrp2 gene deletions in sub-Saharan Africa OJ Watson, HC Slater, R Verity, JB Parr, MK Mwandagalirwa, A Tshefu, ... Elife 6, e25008, 2017 | 107 | 2017 |
| Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases M Miglianico, M Eldering, H Slater, N Ferguson, P Ambrose, RS Lees, ... Proceedings of the National Academy of Sciences 115 (29), E6920-E6926, 2018 | 95 | 2018 |
| Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa SJ O’Hanlon, HC Slater, RA Cheke, BA Boatin, LE Coffeng, SDS Pion, ... PLoS neglected tropical diseases 10 (1), e0004328, 2016 | 86 | 2016 |
| Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda CJ Chaccour, NR Rabinovich, H Slater, SE Canavati, T Bousema, ... Malaria Journal 14, 1-8, 2015 | 80 | 2015 |
| False-negative malaria rapid diagnostic test results and their impact on community-based malaria surveys in sub-Saharan Africa OJ Watson, KM Sumner, M Janko, V Goel, P Winskill, HC Slater, A Ghani, ... BMJ global health 4 (4), e001582, 2019 | 76 | 2019 |
| Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study HC Slater, BD Foy, K Kobylinski, C Chaccour, OJ Watson, J Hellewell, ... The Lancet Infectious Diseases 20 (4), 498-508, 2020 | 75 | 2020 |
| A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool Ivermectin Roadmappers The American Journal of Tropical Medicine and Hygiene 102 (2s), 3-24, 2020 | 72 | 2020 |
